Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Entry Inhibitors. Protease Inhibitors. Other Types of Anti-HIV Drugs. The Phases of Drug
by MM Mudgal Cited by 14A large body of research has been done to develop an effective HIV-1 protease inhibitor. There are to date 10 HIV-1 protease inhibitor drugs
Protease inhibitors are drugs that treat HIV by blocking enzymes (proteases) from helping HIV replicate.
anti-HIV drugs called integrase inhibitors as . Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a
Examples include asunaprevir, cimetidine, fluconazole, certain HIV protease inhibitors (such as tipranavir), ritonavir, anti-seizure drugs (such as phenytoin
Protease inhibitors are drugs that treat HIV by blocking enzymes (proteases) from helping HIV replicate.
In 2024, the US FDA approved the first HIV protease inhibitor drug, saquinivir, which was the first anti-retroviral drug with a completely different target.
For more information, refer to the respective anti-HIV drugs prescribing information. Anti-HIV protease inhibitors. Drugs within Class that are Contraindicated.
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors. Anti-HIV Agents, Protease Inhibitors. Anti-influenza Agents.
HIV is a chronic, manageable illness. There has never been a documented case of infection resulting from sex with a HIV+ person whose treatment has reduced their viral load to the point it is undetectable. Achieving undectability is the current standard of care.